SX-682 + Docetaxel
NCT07667400
National Cancer Institute · Phase 1/2 · Recruiting · Enrollment 120
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
SX-682 + Docetaxel
National Cancer Institute · Phase 1/2 · Recruiting · Enrollment 120
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.